Skip to main content
TipRanks
Go Ultimate75% OFF

Veeva Systems (VEE) Drug Pipeline

13 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Vp-102 / To-208, Vehicle / VehicleWarts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingCantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)May 27, 2026
CantharidinWarts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingLong-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)Feb 24, 2026―
Vehicle, Vp-102Warts, Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (Hpv)Phase IIIRecruitingCantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)Nov 17, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Veeva Systems Inc (DE:VEE) have in its pipeline
Veeva Systems DE:VEE is currently developing the following drugs: Vp-102 / To-208, Vehicle / Vehicle, Cantharidin, Vehicle, Vp-102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.